Silybin, a new iron-chelating agent

被引:95
|
作者
Borsari, M
Gabbi, C
Ghelfi, F
Grandi, R
Saladini, M
Severi, S
Borella, F
机构
[1] Univ Modena, Dipartimento Chim, I-41100 Modena, Italy
[2] Ist Biochim Italiano, Milan, Italy
关键词
silybin; iron chelator; chronic iron overload; Cooley's anemia;
D O I
10.1016/S0162-0134(01)00198-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Silybin, a natural occurring flavolignan isolated from the fruits of Silibum marianum, has been reported to exert antioxidant and free radical scavenging abilities. It was suggested to act also as an iron chelator. The complexation and protonation equilibria of the ferric complex of this compound have been studied by potentiometric, spectrophotometric and electrochemical techniques. The formation of the complex silybin-Ga(III) in anhydrous DMSO-d6 has been studied by H-1 NMR spectroscopy. Mass spectrometry and infrared spectroscopy on silybin-Fe(III) complex confirm all data obtained by H-1 NMR spectroscopy. The experimental results show that silybin binds Fe(III) even at acidic pH. Different ternary complexes were observed at increasing methoxide ion concentration and their stability constants have been calculated. The results show the possible role of silybin in relation to the chelation therapy of chronic iron overload, as occurs in the treatment of Cooley's anemia. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 50 条
  • [1] The iron-chelating potential of silybin in patients with hereditary haemochromatosis
    C Hutchinson
    A Bomford
    C A Geissler
    European Journal of Clinical Nutrition, 2010, 64 : 1239 - 1241
  • [2] The iron-chelating potential of silybin in patients with hereditary haemochromatosis
    Hutchinson, C.
    Bomford, A.
    Geissler, C. A.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2010, 64 (10) : 1239 - 1241
  • [3] ORAL IRON-CHELATING AGENT
    HOPKINS, SJ
    BRITISH MEDICAL JOURNAL, 1978, 2 (6148): : 1375 - 1375
  • [4] DEVELOPMENT OF NEW IRON-CHELATING DRUGS
    GRADY, RW
    GRAZIANO, JH
    AKERS, HA
    CERAMI, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1976, 196 (02): : 478 - 485
  • [5] EFFECT OF AN IRON-CHELATING AGENT ON LYMPHOCYTE-PROLIFERATION
    BOWERN, N
    RAMSHAW, IA
    BADENOCHJONES, P
    DOHERTY, PC
    AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1984, 62 (DEC): : 743 - 754
  • [6] Iron-chelating therapy with the new oral agent ICL670 (Exjadee®)
    Cappellini, MD
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (02) : 289 - 298
  • [7] SYNTHESIS OF NEW ACYLHYDRAZONES AS IRON-CHELATING COMPOUNDS
    EDWARD, JT
    GAUTHIER, M
    CHUBB, FL
    PONKA, P
    JOURNAL OF CHEMICAL AND ENGINEERING DATA, 1988, 33 (04): : 538 - 540
  • [8] INHIBITION OF AUTOIMMUNE NEUROPATHOLOGICAL PROCESS BY TREATMENT WITH AN IRON-CHELATING AGENT
    BOWERN, N
    RAMSHAW, IA
    CLARK, IA
    DOHERTY, PC
    JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (05): : 1532 - 1543
  • [9] IRON-CHELATING THERAPY
    HERSHKO, C
    WEATHERALL, DJ
    CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1988, 26 (04): : 303 - 345
  • [10] INHIBITION OF DELAYED ARTERIAL NARROWING BY THE IRON-CHELATING AGENT DEFEROXAMINE
    HARADA, T
    MAYBERG, MR
    JOURNAL OF NEUROSURGERY, 1992, 77 (05) : 763 - 767